KatzAM: Pathophysiology of heart failure: Identifying targets for pharmacotherapy. Med Clin N Am2003;87:303–316.
2.
The SEOSI Investigators: Survey on heart failure in Italian hospital cardiology units. Eur Heart J1997;18:1457–1464.
3.
OwanTEHodgeDOHergosRM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med2006;355:251–259.
4.
GerdesAMCapassoJM: Structural remodelling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol1995;27:849–856.
5.
ACC/AHA: Guidelines for the evaluation and management of chronic heart failure in adults: Executive summary. J Am Cardiol2001;38:2101–2113.
6.
ZhangJNarulaJ: Molecular biology of myocardial recovery. Surg Clin N Am2004;84:223–242.
7.
DecGWFusterY: Idiopathic dilated cardiomyopathy. N Engl J Med1994;331:1564–1575.
8.
YoshidaFGouldKL: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularisation. J Am Coll Cardiol1993;22:984–997.
9.
WalkerCACrawfordFASpinaleFG: Myocyte contractile dysfunction with hypertrophy and failure: Relevance to cardiac surgery. J Thorac Cardiovasc Surg2000;119:388–400.
10.
EdmondMMockMBDavisKB: Long-term survival of medically treated patients in the coronary artery surgery study (CASS). Circulation1994;90:2645–2657.
11.
KimRJWuERafaelA: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. NEJM2000;343:1445–1453.
12.
WestabyS: Coronary revascularisation in ischaemic cardiomyopathy. Surg Clin N Am2004;84:179–199.
13.
BuckbergG: Left ventricular reconstruction for dilated ischaemic cardiomyopathy: Biology, registry, randomisation and credibility. Eur J Thorac Cardiovasc Surg2006;30:753–761.
14.
HoriiTSumaHIsomuraT: Left ventricular volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure. Ann Thorac Surg2006;82:1349–1355.
15.
BatistaR: Partial left ventriculectomy. The Batista procedure. Eur J Cardiothorac Surg1999;15 (Suppl 1): S12–19.
16.
YanagidaRSugawaraMKawaiAKoyanagiH: Regional differences in myocardial work of the left ventricle in patients with idiopathic dilated cardiomyopathy: Implications for the surgical technique used for left ventriculoplasty. J Thorac Cardiovasc Surg2001;122:600–607.
17.
SumaHIsomuraTHoriiTNomuraF: Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann Thorac Surg2006;82:1344–1348.
18.
O'NeillJOStarlingRCMcCarthyPM: The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. Eur J Cardiothorac Surg2006;30:753–761.
19.
GillinovAMFaberCHoughtalingPLBlackstoneEHLamBKDiazRLytleBWSabikJFCosgroveDMIII: Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg2003;125(6):1350–1362.
20.
DorVSaabMCostePKornaszewskaMMontiglioF: Left ventricular aneurysm: A new surgical approach. Thorac Cardiovasc Surg1989;37:11–19.
21.
DorV: Surgical remodelling of the left ventricle. Surg Clin N Am2004;84:27–43.
22.
AthanasuleasCLStanleyAWJrBuckbergGDDorVDiDonatoMBlackstoneEH: Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodelled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical shape to the LV. J Am Coll Cardiol2001;36:2098–2103.
23.
TulnerSABaxJJBleekerGB: Beneficial haemodynamic and clinical effects of surgical ventricular restoration in patients with ischemic dilated cardiomyopathy. Ann Thorac Surg2006;82:1721–1727.
24.
ArtripJHOzMBurkhoffD: Left ventricular volume reduction surgery for heart failure: A physiologic perspective. J Thorac Cardiovasc Surg2001;122:775–782.
25.
YamaguchiAInoTAdachiHMurataSKamioHOkadaMTsuboiJ: Left ventricular volume predicts postoperative course in patients with ischaemic cardiomyopathy. Ann Thorac Surg1998;65:434–438.
26.
YamaguchiAAdachiHKawahitoKMurataSInoT: Left ventricular reconstruction benefits patients with dilated ischaemic cardiomyopathy. Ann Thorac Surg2005;79(2):456–461.
27.
LeeKSMarwickTHCookSA: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularisation. Circulation1994;90:2687–2694.
28.
HaasFHaetinelCJPickerW: Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischaemic heart disease. J Am Coll Cardiol1997;30:1693–1700.
29.
AllmanKCShawLJHachamovitchRUdelsonJE: Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol2002;39:1151–1158.
30.
BachDSBollingSF: Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end stage cardiomyopathy. Am Heart J1995;129:1165–1170.
31.
McCarthyPMStarlingRCWongJ: Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg1997;114:755–763.
32.
McCarthyJFMcCarthyPMStarlingRC: Partial left ventriculectomy and mitral valve repair for end stage congestive heart failure. Eur J Cardiothorac Surg1998;13:337–343.
BollingSFPaganiFDDeebGMBachDS: Intermediate term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg1998;111:381–388.
35.
BraunJBaxJJVersteeghMIM: Preoperative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischaemic mitral regurgitation. Eur J Cardiothorac Surg2005;27:847–858.
36.
GrossiEACrookeGA: Mitral valve surgery in heart failure: Insights from the Acorn clinical trial. J Thorac Cardiovasc Surg2006;132:455–456.
37.
HausmannHToppHSiniaswskiH: Decision making in end stage coronary artery disease. Revascularisation or heart transplantation. Ann Thorac Surg1997;64:1296–1302.
38.
LiuJYBirkmeyerNJOSandersJH: Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation2000;102:2973.
39.
ConnollyHMOhJKSchaffHV: Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: Result of aortic valve replacement in 52 patients. Circulation2000;102:2952–2958.
40.
MarianiJOuRBaileyM: Tolerance to ischemia and hypoxia is reduced in aged human myocardium. J Thorac Cardiovasc Surg2000;120:660–667.
41.
GoldsteinDJOzMC: Mechanical support for postcardiotomy cardiogenic shock. Semin Thorac Cardiovasc Surg2000;12(3):220–228.
42.
BolliRMarbanE: Molecular and cellular mechanisms of myocardial stunning. Physiol Rev1999;79:609–634.
43.
BavariaJEFurukawaSKreinerG: Myocardial oxygen utilization after reversible global ischemia. J Thorac Cardiovasc Surg1990;100:210–220.
44.
KrauseSMJacobusWEBeckerLC: Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischaemic ‘stunned’ myocardium. Circ Res1989;65:526–530.
45.
KorvaldCElvenesOPYtreboLMSorlieDGMyrmelT: Oxygen-wasting effect of inotropy in the “virtual work model”. Am J Physiol199;276:H1339–H1345.
46.
FowlerMBLaserJAHopkinsGL: Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response. Circulation1986;74(6):1290–1302.
47.
LohseMJEngelhardtSDannerS: Mechanisms of beta-adrenergic receptor desensitisation: From molecular biology to heart failure. Basic Res Cardiol1996;91 (Suppl 2):29–34.
48.
RaoVIvanovJWeiselRD: Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg1996;112(1):38–51.
49.
SmediraNGBlackstoneEH: Postcardiotomy mechanical support: Risk factors and outcomes. Ann Thorac Surg2001;71 (3 Suppl):S60–66.
50.
ChristakisGTWeiselRDFremesSE: Coronary artery bypass surgery in patients with poor ventricular function. J Thorac Cardiovasc Surg1992;103: 1083–1092.
51.
PowellWJDaggettWMMagroAE: Effects of intra-aortic balloon pump counterpulsation on cardiac performance, oxygen consumption and coronary blood flow in dogs. Circ Res1970;26:753–755.
52.
ChristensonJTSomonetFBadelP: Optimal timing of pre-operative intra-aortic balloon pump support in high risk coronary patients. Ann Thorac Surg1999;68:934–939.
53.
DietlCABerkheimerMDWoodsEL: Efficacy and cost effectiveness of pre-operative intra-aortic balloon pump patients with ejection fraction of 0.25 or less. Ann Thorac Surg1996;62:401–408.
54.
TorchianaDFHirschGBuckleyMJ: Intra-aortic balloon pumping for cardiac support: Trends in practice and outcome 1968–1995. J Thorac Cardiovasc Surg1997;113:758–769.
55.
FergusonJJCohenMFreedmanRJ: The current practice of intra-aortic balloon counterpulsation. Results from the Benchmark Registry. J Am Coll Cardiol2001;38:1456–1462.
56.
ChristensonJTCohenMFergusonJJ: Society of Thoracic Surgeons (USA) National Database. Trends in intra-aortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann Thorac Surg2002;74:1086–1091.
57.
WechslerAS: Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg1996;111:998–1000.
58.
AaronsonKDPatelHPaganiFD: Patient selection for left ventricular assist device therapy. Ann Thorac Surg2003;75:S29–35.
59.
TaylorDOEdwardsLBBouckMM: Registry of The International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report — 2006. J Heart Lung Transplant2006;25:869–879.
60.
EntwistleJWC: Short and long term mechanical ventricular assistance towards myocardial recovery. Surg Clin N Am2004:84:201–221.
61.
SamuelLEHolmesECThomasMP: Management of acute cardiac failure with mechanical assist: Experience with the ABIOMED BVS 5000. Ann Thorac Surg2001;71:S67–72.
62.
GuytonRASchonbergerJEvertsP: Post cardiotomy shock: Clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg1993;56:346–356.
63.
PaeWEJrMillerCAMatthewsYPierceWS: Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg1992;104(3):541–552.
64.
GoldingLACrouchRDStewartRW: Postcardiotomy centrifugal mechanical ventricular support. Ann Thorac Surg1992;54(6):1059–1063.
65.
WestabySBalacumaraswamiLEvansBJ: Elective transfer from cardiopulmonary bypass to centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg2007;133(2):577–578.
66.
De RobertisFBirksEJRogersP: Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant2006;25:181–6.
67.
ArgenzianoMChoudhriAFMoazamiN: Randomised double blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg1998;65:340–345.
68.
FullertonDAMcIntyreRCJr: Inhaled nitric oxide: Therapeutic applications in cardiothoracic surgery. Ann Thorac Surg1996;61:1856–1864.
69.
FullertonDAJaggersJPiedalueF: Effective control of refractory pulmonary hypertension after cardiac surgery. J Thorac Cardiovasc Surg1997: 113:365–368.
70.
FullertonDAJonesSDJaggersJ: Effective control of pulmonary vascular resistance with inhaled nitric oxide following cardiac operation. J Thorac Cardiovasc1996;111:753–763.
71.
LietzKMillerLW: Will left ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol2005;20:132–137.
72.
HuntSA: Taking heart — Cardiac transplantation, past, present and future. N Engl J Med2006;355:231–235.
73.
WestabyS: Ventricular assist device as destination therapy. Surg Clin N Am2004;84:91–123.
74.
JarvikRWestabySKatsumataT: LVAD power delivery: A percutaneous approach to avoid infection. Ann Thorac Surg1998;64:470–473.
75.
RoseEAGelijnsACMoskowitzAJ: Randomised Evaulation of Mechnical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med2001;345:1435–1443.
76.
WestabySFrazierOHBanningA: Six years of continuous circulatory support. N Engl J Med2006;355:325–327.
77.
SaitoSNishinkakaTWestabyS: Hemodynamics of chronic non-pulsatile blood flow: Implications for LVAD development. Surg Clin N Am2004;84:61–74.
78.
WollerKCDrexlerH: Clinical applications of stem cells for the heart. Circ Res2005;96:151–163.
79.
AnversaPKajsturaJLeriABolliR: Life and death of cardiac stem cells: A paradigm shift in cardiac biology. Circulation2006;113:1451–1463.
80.
BonarosNRaufDWolfE: Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischaemic heart failure. J Thorac Cardiovasc Surg2006;132:1321–1328.
81.
SalemRDenaoultAYCoutureP: Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. Brit J Anaesth2006;97:292–296.